TriSalus Life Sciences (TLSI) Tops Q1 EPS by 3c May 12, 2026 05:22PM
TriSalus reports Q1 revenue of $8.9 million, raises 2026 guidance May 12, 2026 04:01PM
TriSalus begins clinical trial for liver tumor drug delivery system May 4, 2026 05:27PM
TriSalus Life Sciences names Richard Marshall as chief medical officer Apr 7, 2026 09:17AM
TriSalus publishes study showing improved drug delivery to liver tumors Mar 18, 2026 08:03AM


Mar 6, 2026 10:53AM Jones Trading Reiterates Buy Rating on TriSalus Life Sciences, Inc. (TLSI) following earnings
Mar 5, 2026 04:13PM TriSalus Life Sciences (TLSI) Misses Q4 EPS by 21c
Jan 12, 2026 07:01AM TriSalus reports Q4 revenue of $13.2 million, up 60% year-over-year
Nov 14, 2025 02:32AM Canaccord Genuity Reiterates Buy Rating on TriSalus Life Sciences, Inc. (TLSI)
Nov 13, 2025 05:28PM TriSalus Life Sciences (TLSI) Misses Q3 EPS by 96c
Nov 13, 2025 04:41PM TriSalus Life Sciences (TLSI) files $150M mixed shelf
Nov 13, 2025 02:01AM Canaccord Genuity Reiterates Buy Rating on TriSalus Life Sciences, Inc. (TLSI)
Aug 11, 2025 08:03AM TriSalus publishes thyroid embolization study results
Jul 24, 2025 05:58PM TriSalus completes exchange offer for preferred stock
Jun 23, 2025 05:31PM TriSalus Life Sciences (TLSI) commences exchange offer
Jun 9, 2025 07:13AM Cantor Fitzgerald Reiterates Overweight Rating on TriSalus Life Sciences, Inc. (TLSI)
Jun 2, 2025 06:39AM Cantor Fitzgerald Reiterates Overweight Rating on TriSalus Life Sciences, Inc. (TLSI)
May 30, 2025 07:01AM TriSalus Life Sciences (TLSI) Announces CFO Change
May 19, 2025 06:41AM Cantor Fitzgerald Reiterates Overweight Rating on TriSalus Life Sciences, Inc. (TLSI)
Apr 30, 2025 11:09AM Northland Reiterates Outperform Rating on TriSalus Life Sciences, Inc. (TLSI)
Apr 30, 2025 08:00AM TriSalus Life Sciences (TLSI) Announces $22.0 Million Private Placement Preliminary Q1 2025 Unaudited Financial Results
Mar 17, 2025 07:38AM Cantor Fitzgerald newsletter says Elutia best, Anteris worst performer
Feb 13, 2025 08:54AM Lake Street Capital Markets Starts TriSalus Life Sciences, Inc. (TLSI) at Buy
Feb 3, 2025 04:06PM TriSalus Life Sciences (TLSI) Appoints William J. Valle and Gary B. Gordon to its Board
Jan 23, 2025 08:01AM TriSalus Life Sciences (TLSI) Reports Prelim Q4 Results
Jan 8, 2025 08:05AM TriSalus Life Sciences (TLSI) Announces Leadership Changes
Nov 15, 2024 07:07AM TriSalus Life Sciences, Inc. (TLSI) PT Lowered to $11 at Canaccord Genuity
Nov 11, 2024 03:18AM Roth/MKM Starts TriSalus Life Sciences, Inc. (TLSI) at Buy
Oct 25, 2024 09:01AM Northland Starts TriSalus Life Sciences, Inc. (TLSI) at Outperform
Sep 26, 2024 07:02AM TriSalus Life Sciences (TLSI) Appoints Riad Salem to its Board
Sep 23, 2024 07:03AM TriSalus Life Sciences (TLSI) Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With P
Sep 16, 2024 06:06AM Oppenheimer Starts TriSalus Life Sciences, Inc. (TLSI) at Outperform, PT $10
Aug 16, 2024 02:54PM Jones Trading Reiterates Buy Rating on TriSalus Life Sciences, Inc. (TLSI)
Jul 2, 2024 05:51AM Canaccord Genuity Reiterates Buy Rating on TriSalus Life Sciences, Inc. (TLSI)